Needle Free Injections - Medical Devices Pipeline Assessment, 2017

  • ID: 4338910
  • Report
  • 141 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Boston Scientific Corp
  • Crossject SA
  • Enable Injections, LLC
  • Eternity Healthcare Inc.
  • EuroJet Medical Kft.
  • MORE
Needle Free Injections - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Needle Free Injections - Medical Devices Pipeline Assessment, 2017" provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Needle Free Injections under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Needle Free Injections under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Boston Scientific Corp
  • Crossject SA
  • Enable Injections, LLC
  • Eternity Healthcare Inc.
  • EuroJet Medical Kft.
  • MORE
1 Table of Contents
2 Introduction
2.1 Needle Free Injections Overview
3 Products under Development
3.1 Needle Free Injections - Pipeline Products by Stage of Development
3.2 Needle Free Injections - Pipeline Products by Territory
3.3 Needle Free Injections - Pipeline Products by Regulatory Path
3.4 Needle Free Injections - Pipeline Products by Estimated Approval Date
3.5 Needle Free Injections - Ongoing Clinical Trials
4 Needle Free Injections - Pipeline Products under Development by Companies
4.1 Needle Free Injections Companies - Pipeline Products by Stage of Development
4.2 Needle Free Injections - Pipeline Products by Stage of Development
5 Needle Free Injections Companies and Product Overview
5.1 B. Braun Melsungen AG Company Overview
5.1.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
5.2 Boston Scientific Corp Company Overview
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Crossject SA Company Overview
5.3.1 Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Enable Injections, LLC Company Overview
5.4.1 Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Eternity Healthcare Inc. Company Overview
5.5.1 Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 EuroJet Medical Kft. Company Overview
5.6.1 EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Glide Pharmaceutical Technologies Ltd Company Overview
5.7.1 Glide Pharmaceutical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Inovio Pharmaceuticals Inc Company Overview
5.8.1 Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medical International Technologies (Mit Canada) Inc Company Overview
5.9.1 Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 PharmaJet Inc Company Overview
5.10.1 PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Teva Pharmaceutical Industries Ltd Company Overview
5.11.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Needle Free Injections- Recent Developments
6.1 Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell
6.2 Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced
6.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.4 Jun 15, 2017: Consort Medical: Full year results
6.5 Jun 13, 2017: Needle-free Injection Linked to Increasing Workplace Flu Shot Compliance
6.6 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund
6.7 Jun 06, 2017: Valeritas Appoints Peter J. Devlin to Chairman of its Board of Directors
6.8 May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results
6.9 May 12, 2017: Valeritas Reports First Quarter 2017 Financial Results
6.10 May 11, 2017: Teva Reports First Quarter 2017 Financial Results
6.11 May 10, 2017: ICU Medical Announces First Quarter 2017 Results
6.12 May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results
6.13 May 04, 2017: Zogenix Reports First Quarter 2017 Financial Results
6.14 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results
6.15 Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio
6.16 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
6.17 Apr 26, 2017: Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer
6.18 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017
6.19 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board
6.20 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors
6.21 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency
6.22 Mar 31, 2017: B. Braun continues its sales and earnings growth
6.23 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal
6.24 Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results
6.25 Mar 14, 2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results
6.26 Mar 09, 2017: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results
6.27 Mar 07, 2017: PharmaJet partners with Serum Institute to Launch Needle-Free MMR Vaccine
6.28 Mar 06, 2017: CROSSJECT receives authorization to conduct Zeneo Midazolam bioequivalence study
6.29 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results
6.30 Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017
6.31 Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers
6.32 Feb 22, 2017: Change in the B. Braun Management Board
6.33 Feb 21, 2017: Valeritas Reports Fourth Quarter and Full Year 2016 Financial Results
6.34 Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha
6.35 Feb 14, 2017: Expanded Vaccine offering for PharmaJet Needle-free Device
6.36 Feb 13, 2017: Teva Reports Full Year and Fourth Quarter 2016 Financial Results
6.37 Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure
6.38 Feb 09, 2017: Terumo Announces Change of Executive Officers
6.39 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
6.40 Feb 06, 2017: Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
6.41 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
6.42 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results
6.43 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
6.44 Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President
6.45 Jan 31, 2017: Terumo Opens a Branch in Yangon
6.46 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration
6.47 Jan 10, 2017: Milestone Certification Achieved For Eternity Healthcare’s Lenis Device
6.48 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System
6.49 Jan 06, 2017: Teva Provides 2017 Financial Outlook
6.50 Jan 05, 2017: Zogenix Announces CFO Transition
6.51 Dec 22, 2016: Teva Reaches Settlement with Government on FCPA
6.52 Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
6.53 Dec 14, 2016: Consort Medical: Directorate Change
6.54 Dec 13, 2016: Eternity Healthcare Moves to Next Stage Regulatory Approval Phase with Lenis
6.55 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy
6.56 Dec 06, 2016: Consort Medical Reports Interim Results For The Six Months Ended 31 October 2016
6.57 Dec 05, 2016: Teva Appoints Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson
6.58 Nov 30, 2016: Valeritas Elects Joe Mandato, Ph.D., Experienced Medical Device Executive and Investor, to Board of Directors
6.59 Nov 25, 2016: Consort Medical: CFO Appointment
6.60 Nov 15, 2016: Teva Reports Third Quarter 2016 Results
6.61 Nov 14, 2016: BioSyent Pharma Launches New Urgent Care Product
6.62 Nov 10, 2016: Valeritas Reports Third Quarter 2016 Financial Results
6.63 Nov 09, 2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results
6.64 Nov 09, 2016: Aradigm Announces Third Quarter 2016 Financial Results
6.65 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results
6.66 Nov 08, 2016: Zogenix Provides Corporate Update and Reports Third Quarter 2016 Financial Results
6.67 Nov 08, 2016: Teva Announces Appointment of New Chief Legal Officer
6.68 Oct 31, 2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
6.69 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
6.70 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
6.71 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results
6.72 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
6.73 Oct 04, 2016: PharmaJet Needle-Free Flu Shots Offered in Workplace Health Clinics
6.74 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy
6.75 Sep 22, 2016: Industry Veteran Katherine D. Crothall, PhD to Join Valeritas Board of Directors
6.76 Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development
6.77 Aug 30, 2016: PharmaJet Collaborates with World Health Organization
6.78 Aug 17, 2016: Consort Medical Announces Directorate Change
6.79 Aug 16, 2016: Valeritas Appoints Erick J. Lucera as Chief Financial Officer
6.80 Aug 10, 2016: Aradigm Announces Second Quarter 2016 Financial Results
6.81 Aug 10, 2016: Valeritas Reports Second Quarter 2016 Financial Results
6.82 Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results
6.83 Aug 09, 2016: Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results
6.84 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results
6.85 Aug 04, 2016: Teva Reports Second Quarter 2016 Results
6.86 Aug 03, 2016: NIH using PharmaJet in DNA Vaccine Clinical Trial for Zika Virus
6.87 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
6.88 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Needle Free Injections - Pipeline Products by Stage of Development
Table 2: Needle Free Injections - Pipeline Products by Territory
Table 3: Needle Free Injections - Pipeline Products by Regulatory Path
Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
Table 5: Needle Free Injections - Ongoing Clinical Trials
Table 6: Needle Free Injections Companies - Pipeline Products by Stage of Development
Table 7: Needle Free Injections - Pipeline Products by Stage of Development
Table 8: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Needle-Free System - Product Status
Table 10: Needle-Free System - Product Description
Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 12: JetTouch System - Overactive Bladder - Product Status
Table 13: JetTouch System - Overactive Bladder - Product Description
Table 14: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Zeneo ID Human Needle-Free Injection Device - Product Status
Table 16: Zeneo ID Human Needle-Free Injection Device - Product Description
Table 17: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status
Table 18: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description
Table 19: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status
Table 20: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description
Table 21: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status
Table 22: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description
Table 23: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status
Table 24: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description
Table 25: Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Enable Injector - Product Status
Table 27: Enable Injector - Product Description
Table 28: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Multi Channel Needle-Free Injection Device - Product Status
Table 30: Multi Channel Needle-Free Injection Device - Product Description
Table 31: EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview
Table 32: E-Jet 500 Needle Free Injector - Product Status
Table 33: E-Jet 500 Needle Free Injector - Product Description
Table 34: Glide Pharmaceutical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Glide SDI - Product Status
Table 36: Glide SDI - Product Description
Table 37: Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Iject R Pre-Filled Syringe - Product Status
Table 39: Iject R Pre-Filled Syringe - Product Description
Table 40: Intradermal Pen Injector - Product Status
Table 41: Intradermal Pen Injector - Product Description
Table 42: Intradermal Syringe - Product Status
Table 43: Intradermal Syringe - Product Description
Table 44: Mega Jet - Product Status
Table 45: Mega Jet - Product Description
Table 46: Multi-Port Orifices - Product Status
Table 47: Multi-Port Orifices - Product Description
Table 48: Needle-Free Vaccine Delivery Device - Product Status
Table 49: Needle-Free Vaccine Delivery Device - Product Description
Table 50: Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: MED-JET MBX Injector - Product Status
Table 52: MED-JET MBX Injector - Product Description
Table 53: MESO-JET - Product Status
Table 54: MESO-JET - Product Description
Table 55: MIT-H-III - Product Status
Table 56: MIT-H-III - Product Description
Table 57: MIT-H-IV-1 - Product Status
Table 58: MIT-H-IV-1 - Product Description
Table 59: MIT-H-IV-5 - Product Status
Table 60: MIT-H-IV-5 - Product Description
Table 61: MIT-H-VI Dental Injector - Product Status
Table 62: MIT-H-VI Dental Injector - Product Description
Table 63: PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Tropis - Product Status
Table 65: Tropis - Product Description
Table 66: Variable Volume Drug Delivery Device - Product Status
Table 67: Variable Volume Drug Delivery Device - Product Description
Table 68: PharmaJet Inc - Ongoing Clinical Trials Overview
Table 69: Tropis - A Pragmatic Trial to Quantitatively and Qualitatively Assess Different Techniques for the ID Administration of Fractional Dose IPV in a Campaign Setting in the Gambia
Table 70: Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 71: MicroDose Needlefree System - Product Status
Table 72: MicroDose Needlefree System - Product Description
Table 73: Glossary

List of Figures
Figure 1: Needle Free Injections - Pipeline Products by Stage of Development
Figure 2: Needle Free Injections - Pipeline Products by Territory
Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path
Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
Figure 5: Needle Free Injections - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Boston Scientific Corp
  • Crossject SA
  • Enable Injections, LLC
  • Eternity Healthcare Inc.
  • EuroJet Medical Kft.
  • Glide Pharmaceutical Technologies Ltd
  • Inovio Pharmaceuticals Inc
  • Medical International Technologies (Mit Canada) Inc
  • PharmaJet Inc
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll